CalciMedica amends loan with Avenue: extends maturity to 2029, ups convertible amount to $3M

CalciMedica, Inc.

Loan principal $10M unchanged; interest-only extended to Sep 2027, maturity to Sep 2029.
Lender's conversion option increased from $1M to $3M at $1.00/share; new 1M-share warrant issued at same price.
Company granted monthly Put Option to force conversion up to 20% of 15-day avg volume if VWAP >1.5x conversion price.
Existing warrant exercise price reduced from $2.32 to $1.00; beneficial ownership cap set at 4.99% (expandable to 19.99%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.